Mesoblast (MEOBF) FCF Margin Growth (1y) (2015 - 2023)
Powered by 
Analysis
Mesoblast (MEOBF) FCF Margin Growth (1y) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 682.00 |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 1.20 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 5,823.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -189.00 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 26,580.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -1.30 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 226,818.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 1,141.00 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 1,854.00 |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 662,330.00 |
| Mar 31, 2023 | -323,716.00 |
| Dec 31, 2022 | 128,628.00 |
| Sep 30, 2022 | 44,419.00 |
| Jun 30, 2022 | 27,490.00 |
| Mar 31, 2022 | 50,615.00 |
| Dec 31, 2021 | 84,933.00 |
| Sep 30, 2021 | 266,476.00 |
| Mar 31, 2021 | -116,092.00 |
| Dec 31, 2020 | -89,676.00 |
| Sep 30, 2020 | -206,713.00 |
| Mar 31, 2020 | 157,954.00 |
| Dec 31, 2019 | -36,316.00 |
| Sep 30, 2019 | 7,669.00 |
| Mar 31, 2019 | 13,558.00 |
| Dec 31, 2018 | 631.00 |
| Sep 30, 2018 | 156,595.00 |
| Jun 30, 2018 | 295,293.00 |
| Mar 31, 2018 | 101,722.00 |
| Dec 31, 2017 | 453,213.00 |